A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

Cancer
Esophageal Cancer

Results
Download

Study results

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 English (PDF, 0.3 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 Korean (PDF, 0.5 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 Thai (PDF, 0.5 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 China Chinese (PDF, 0.5 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 Hong Kong Chinese (PDF, 0.6 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 Taiwan Chinese (PDF, 0.5 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

Study results

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 English (PDF, 0.3 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 Korean (PDF, 0.5 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 Thai (PDF, 0.5 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 China Chinese (PDF, 0.5 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 Hong Kong Chinese (PDF, 0.6 MB)

LPS YO42138 SKYSCRAPER-08 Final Results July 2026 Taiwan Chinese (PDF, 0.5 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

For the latest version of this information please go to www.forpatients.roche.com